Research & Development
“We aim to develop novel biopharmaceuticals by leveraging
our exceptional scientific talent pool and developmental capabilities.”
- Harish V. Iyer, General Manager R&D
Biocon’s discovery-led R&D focuses on the entire drug development pathway - from process development, to non-clinical and clinical research. The depth and breadth of our technological and scientific expertise enables us to develop new and affordable therapeutics for the world’s most debilitating diseases. R&D’s ability to leverage frontier science, from cloning right through to identifying novel clinical biomarkers, continues to advance Biocon’s reputation as a leading innovator company.
We have on our R&D team, outstanding scientists from the best institutes around the world. Our hard-to-find skill sets, continuous interaction with international thought leaders and participation in technical programs to enable knowledge creation, positioning Biocon’s R&D for challenging biopharmaceutical development. |
